ASTRAZENECA
Oxford COVID-19 Vaccine Should be Available for Public by April 2021, Maximum Price Rs 1,000: Seram Institute CEO Adar Poonawalla
COVID-19 Vaccination Update: Pfizer, BioNTech Offer Brazil Coronavirus Vaccination Plan for 2021
COVID-19 Vaccine Covishield May Get Emergency Use Authorisation From India in December 2020, Says Report
India Needs 1.7 Billion COVID-19 Vaccine Doses for Adult Population, Says Credit Suisse Research
When Will COVID-19 Vaccine Covishield, Developed by Oxford-AstraZeneca, Be Available? Adar Poonawalla Responds
AstraZeneca: COVID-19 Vaccine Shows ‘Strong Immune Response' in All Adult Groups, Says Oxford University
COVID-19 Vaccine Update: Johnson & Johnson Says Vaccine Could Be Available from January 2021; AstraZeneca Produces Robust Immune Response
AstraZeneca-Oxford COVID-19 Vaccine Trial Volunteer in Brazil Dies, AstraZeneca Shares Turn Negative
COVID-19 Vaccine: Apollo Hospitals Ready to Administer One Million Coronavirus Vaccines Daily
When Will India Get COVID-19 Vaccine? Here's Where AstraZeneca, Sputnik V And Other Vaccine Trials Stand in India
COVID-19 Vaccine Update: Johnson & Johnson Pauses Coronavirus Vaccine Trials Due to Unexplained Illness in a Study Participant
COVID-19 Treatment: AstraZeneca’s Antibody Drug AZD7442 Moves Into Phase 3 Clinical Trials
COVID-19 Vaccine Update: Serum Institute of India to Produce Additional 100 Million Doses of Coronavirus Vaccine in 2021
COVID-19 Vaccine Update: Phase 3 Human Clinical Trial of Oxford Vaccine Covishield Begins in Pune
AstraZeneca's Trial Blueprint Says 'Goal is to Develop COVID-19 Vaccine With 50% Effectiveness'
Oxford-AstraZeneca's COVID-19 Vaccine Trials Resumes in UK After Brief Pause Over Volunteer's Illness
Google Trends